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Chronic dyspnoea is a devastating symptom that debilitates millions of people worldwide. It
causes a large burden on both patient and carer, and significant costs to society and health
services. Treatment options are limited. Much effort has been directed at optimising lung func-
tion and improving exercise capacity, however, the brain mechanisms underlying dyspnoea
perception have received less attention.
In this review, we focus on cognitive and affective aspects of dyspnoea and discuss how
novel neuroimaging methods can provide quantitative measures of these subjective sensa-
tions. We draw parallels with the more advanced field of chronic pain, and explain some of
the challenges faced when imaging dyspnoea.
To date, brain mechanisms of dyspnoea have been investigated in a handful of studies by
a limitednumberof authors. Thesehave foundconsistentactivation in the insular cortex, theante-
rior cingulate cortex and the amygdala. Novel neuroimaging methods and an improved under-
standing of perceptual mechanisms underlying dyspnoea now position us to transform dyspnoea
research. Future research should investigate howbrain regions associatedwith dyspnoea interact,
as well as accurately correlate this neuronal activation with reliable behavioural measures.
A better understanding of the brain processes underlying dyspnoea perception will lead to new
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Dyspnoea is the uncomfortable breathlessness suffered by
millions of patients with illnesses as diverse as cardiac failure,
cancer and chronic obstructive pulmonary disease (COPD).
Few sensations can match dyspnoea for unpleasantness, and
even with an artificial dyspnoea stimulus delivered under
controlled laboratory conditions, subjects have reported
a feeling of impending death.1 In COPD, dyspnoea is an inde-
pendent predictor of mortality as well as a cause for
morbidity.2 For simplicity, dyspnoea is often described in
terms of air hunger, chest tightness, respiratory effort or
a combination of these,3 although the clinical state is in fact
more complicated. Air hunger is the conscious sensation of
being starvedofair,4 respiratoryeffort is frequently described
in terms ofwork4 and chest tightness appears to be associated
with bronchoconstriction.5 These can be independently
manipulated in an experimental model of dyspnoea.6
Most healthy individuals will experience breathlessness,
for example during physical exercise or conscious hyper-
ventilation. These transient, reversible sensations are likely
to be qualitatively different from the sensations of breath-
lessness experienced by dyspnoeic patients, which are, by
their very nature, associated with threat to survival and
linked to disease-related fear and anxieties. Terms such as
‘rewarded’ breathing (respiratory effort is matched by
ventilation) and ‘unrewarded’ breathing (respiratory effort
is not matched by ventilation, leading to an unpleasant
sensation) may be used to differentiate between the normal
breathlessness experienced by healthy individuals and the
breathlessness suffered by patients.
The symptoms of dyspnoea vary between patients and
are not fully explained by differences in disease severity
(e.g. spirometric measures of lung function). Patients may
exhibit low disease severity but report high levels of
dyspnoea,7 or vice versa.8 Indeed, in idiopathic hyperven-
tilation, no lung abnormalities are identified.9 This suggests
that the perception of dyspnoea is not necessarily linearly
related to the sensory input, but is modulated by cognitive
and affective factors.10 Cognitive factors include attention,
expectation and catastrophising, and affective factors
include depression, anxiety and short-lasting moods.
Up until recently, most research into dyspnoea has focused
on the lungs and muscles, while the cognitive and affective
aspects have been less investigated.11 In this paper, we will
outline our current understanding of cognitive and affective
factors in dyspnoea, and address how neuroimaging may
provide objectivemeasures of brainmechanisms in dyspnoea.Addressing the multidimensionality of
dyspnoea
A growing body of literature, including consensus statements
from the American Thoracic Society12 and the American
College of Chest Physicians,13 supports the view that chronic
dyspnoea has a cognitive and affective dimension that is
(partly) separate from the sensory intensity of breathless-
ness,10,14,15 i.e. a multidimensional model (Fig. 1). However,
our understanding of the cognitive and affective dimension
remains limited.
Chronic dyspnoea has been linked to depression and
anxiety,16,17 and may be exacerbated by negative
emotions,18,19 including worry and fear.6 Negative emotions
and anxiety have also been linked to the perception of dysp-
noea in healthy volunteers.20 In COPD patients, high depres-
sion scores are consistently associated with poor exercise
performance,21 although the causal relationship has yet to be
determined. Distraction may improve exercise tolerance in
COPD patients,22,23 suggesting a role for attention in the
modulation of dyspnoea perception. Furthermore, expecta-
tion and affective factors may provide a possible explanation
for variation in symptom perception that cannot be explained
by severity of physical symptoms (reviewed by Jansson
et al.15). Studies using electroencephalography (EEG) during
brief inspiratory occlusions (less than 1 s) demonstrate that
attention24,25 and affective states26 may modulate respira-
tory-related evoked potentials (RREP), specifically the P300/
P3 peak of the RREP. This further supports the importance of
attention and affective states in respiratory perception.
Pulmonary rehabilitation is a therapy that successfully
alleviates the feeling of dyspnoea in patients suffering from
COPD, yet does not affect lung function. A 2007 Cochrane
review, taking into account 31 randomised controlled trials,
found no significant change in maximal exercise capacity
following pulmonary rehabilitation, but reported significant
reduction in perception of dyspnoea and fatigue, and
improvements in functional exercise capacity that were less
striking.27 More importantly, Carrieri-Kohlman et al.28 have
found that an exercise programme (one component of
pulmonary rehabilitation) lowers dyspnoea-related anxiety
to a greater extent than the dyspnoea itself. If the
improvements seen with pulmonary rehabilitation were
solely due to muscle training, then one would expect an
equal decrease in dyspnoea intensity and dyspnoea-related
anxiety in these patients. Exercise programmes have also
been linked to improvements in cognitive function in COPD
patients.29 In addition, pulmonary rehabilitation includes
Figure 1 Schematic illustrating factors that influence
afferent respiratory signalling to affect the perception of
dyspnoea and respiratory drive.
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providing coping strategies, giving information and under-
taking group therapy, which are components also found in
cognitive behavioural therapy, an established treatment
program for chronic pain.30 As a therapy for chronic pain,
cognitive behavioural therapy lowers anxiety levels and
reduces symptom perception31 without altering the under-
lying disease process. Pulmonary rehabilitation may reduce
dyspnoea in a similar fashion for COPD.
Borrowing ideas from pain research
Comparing pain and dyspnoea has recently garnered atten-
tion,32,33 including comparing the multidimensionality of
dyspnoea with the more established multidimensional pain
model.34 Pain, like dyspnoea, is a highly subjective sensation,
oftenassociatedwithnegativeemotions.35Bothdyspnoeaand
pain are closely linked to chronic and often severe conditions
and the sensory intensity level in both conditions may vary
irrespective of disease state. While studies on dyspnoea to
date have largely focussed on anxiety and depression, themultidimensional pain model has grown to distinguish
between and incorporate several centrally mediated compo-
nents.36,37 Expectation38 and threat perception39 may
heighten the pain experience (and also anxiety levels40), and
pain-related fear is a better predictor for disability than the
sensory intensity itself.41 Positive emotions may reduce while
negativeemotionsmay increaseperceived pain,42,43 similar to
what has been observed in dyspnoea.18,19 Attention may
modulate pain perception i.e. distraction may reduce the
perception of pain intensity and vice versa.44 In pain, atten-
tion may alter both neural activation and its functional inte-
gration,36 and this modulation has been linked to activation in
the periaqueductal grey (PAG) of the brainstem.45
Addressing cognitive and affective factors that are well
known in the pain field could provide further insight into the
morbidity of chronic dyspnoea. Indeed, the novel dyspnoea-
12 questionnaire specifically includes items on the affective
dimension of dyspnoea,46 studies on asthmatic patients have
recently begun to incorporate assessments of catastro-
phic thinking in addition to anxiety assessments,47 and the
role of attention states has also garnered some interest.22
Furthermore, based on the role of anxiety in the treat-
ment of COPD using pulmonary rehabilitation,27 it is
reasonable to expect that previous experiences and expec-
tations (i.e. memory and learning) are important to a similar
extent in dyspnoea as has been shown in pain.48 Indeed,
studies using conditioning paradigms, such as different
odours coupled with various respiratory challenges, have
shown that previous experiences can subsequently alter
respiratory responses and perception.49e52
While pain and dyspnoea certainly share some common
features, it would be equally interesting to explore the brain
mechanisms by which pain and dyspnoea differ, by addressing
the factors that are unique to dyspnoea. Some of these
differences have already been outlined in an earlier review.35
To fully understand the cognitive and affective dimension of
dyspnoea, we should investigate the brain mechanisms
underlying these factors rather than treating the brain as
ablackbox,andtodothis, neuroimaging isoneofourbestbets.
Neuroimaging of dyspnoea
To date, neuroimaging studies on dyspnoea are rare. Early
neuroimaging studies have demonstrated the importance of
the insular cortex53e58 and also implied a role for the
anterior cingulate cortex58,59 and the amygdala54e56,58,60 in
experimental dyspnoea (Table 1).
It is difficult to draw solid conclusions based on these
results due to both the limited number of studies and to
the great variation in experimental methods used in these
studies (for the studies listed in Table 1, no less than three
different types of respiratory stimuli have been employed).
For example, while it is possible that the activation of the
anterior cingulate reported by Evans et al.58 may have been
a consequence of using a constantly changing stimulus, it is
equally possible that the absence of activation in the same
region observed by Von Leupoldt et al.60 could have been
due to a type 2 error (perhaps physiological noise61). As such,
we may still only speculate on the role of the anterior
cingulate in dyspnoea. Interpretation of results is further
complicated as these experimental methods may to various
degrees also cause changes in neural control of breathing
Table 1 Brain regions identified in neuroimaging studies of dyspnoea.
Author(s) Year Brain region activations reported Method Stimulus
Liotti et al.55 2001 Amygdala/periamygdala PET Hypercapnia, CO2 baseline raised from
41.0 mmHg to 66.1 mmHg for w3 minBrannan et al.54 Anterior insula/claustrum
Parsons et al.56 Bilateral anterior temporal poles
Bilateral lingual gyri
Cerebellum
Cingulate cortex
Dorsal anterior/middle cingulate gyrus
Fusiform gyri
Hypothalamus
Hippocampus
Inferior pre- and orbitofrontal cortexa
Left inferior parietal lobulea
Left lentiform/caudate nucleia
Left thalamusa
Lingual/middle temporal gyrus
Midbrain tegmentum
Parahippocampal regions
Periaqueductal grey
Pons
Pulvinar
Right middle insulaa
Right precentral gyrusa
Right dorsal prefrontal cortex
Banzett et al.53 2000 Mid/anterior insula PET Hypercapnia, PETCO2 constant at 44.0 mmHg
and high and low tidal volume for 210 s
Peiffer et al.57 2001 Cerebellar vermis PET Inspiratory and expiratory resistive loads,
13.3 cmH2O for 90 sLeft medial pons
Right anterior insula/claustrum
Evans et al.58 2002 Amygdala BOLD
FMRI
Mechanical ventilation, PETCO2 constant at 41.0
mmHg and high and low tidal volume for 60 sAnterior cingulate
Anterior insula
Basal ganglia
Cerebellum
Operculum
Prefrontal cortex
Thalamus
Peiffer et al.59 2008 Anterior cingulate cortexb PET Inspiratory and expiratory resistive loads,
19.4 cmH2O for 100 sCaudate nucleus
Cerebellum
Prefrontal cortexa
Premotor cortex
Von Leupoldt
et al.60
2008 Amygdalac BOLD
FMRI
Inspiratory resistive load, 13.3 cmH2O for 24 s
Bilateral insular cortex
Right anterior insular cortexc
Sensorimotor cortex
Supplemental motor area
Von Leupoldt
et al.84
2009 Insula BOLD
FMRI
Inspiratory resistive load, 13.3 cmH2O (patients)
and 12.2 cmH2O (controls) for 24 sPeriaqueductal gray
Von Leupoldt
et al.83
2009 Amygdala BOLD
FMRI
Inspiratory resistive load, 12.2 cmH2O for 24 s
Dorsal/rostral anterior cingulate cortex
Insula
Medial thalamus
Operculum/Somatosensory cortex II
Sensorymotor cortex
Supplementary motor area
(PET, Positron Emission Tomography; BOLD, Blood Oxygen Level Dependent; FMRI, Functional Magnetic Resonance Imaging, PETCO2 , end-
tidal PCO2).
a deactivation.
b associated with relief from dyspnoea.
c associated with perceived unpleasantness of dyspnoea.
Dyspnoea and the brain 813that is not specific to dyspnoea. Last but certainly not least,
all neuroimaging studies to date have investigated acute
experimental dyspnoea in healthy volunteers, but no studies
have yet looked at chronic dyspnoea. Acute experimental
dyspnoea induced in healthy volunteers is likely to be qual-
itatively very different from the chronic dyspnoea experi-
enced by patients, since the former is experienced in a safe,
experimental setting while the latter is often influenced by
disease-related fear and anxiety. This is an area that requires
further study.
There have also been a few neuroimaging studies inves-
tigating brain mechanisms of control of respiration other
than dyspnoea. Brainstemactivation has been observed both
during volitional control of breathing (breath hold, voluntary
hyperpnoea, Valsalva manoeuvre)57,62e64 and during auto-
matic or unconscious control of breathing (chemo-stimu-
lated ventilation).65,66 Studies of volitional breathing have
suggested the involvement of a range of cortical areas
involved in breathing,62,64,67,68 of which some, including the
insular cortex64,67 and caudate nucleus,67 have also been
identified in dyspnoea.58,59 Similarly, neuroimaging studies
on chemo-stimulated increases in ventilation have shown
activation in the basal ganglia, parietal cortex, cerebellum,
midbrain, occipital lobe, the frontal cortex69,70 and the
limbic system.66,70 While not addressing dyspnoea directly,
imaging studies on respiratory control may assist in identi-
fying and separating the brain regions that are involved in
other breathing responses from those that are unique for
dyspnoea.
Pain research as a roadmap
Whereas neuroimaging of dyspnoea is in its infancy, these
techniques have revolutionised our understanding of mech-
anisms underlying chronic pain perception. Neuroimaging
has led to the identification of what has (perhaps unfortu-
nately71) been termed the pain matrix, which includes the
thalamus and the primary and secondary somatosensory,
insular, anterior cingulate and prefrontal cortices.72,73
These brain regions are associated with, but not unique to,
pain, and comprise a network which activation may be
altered depending on the factors involved in pain percep-
tion.71 Furthermore, several modulatory networks that may
control nociceptive processing in the central nervous system
have also been identified. Themost extensively investigated
of these is the descending pain modulatory system, which is
thought to underlie the analgesia observed during fight-or-
flight responses and includes the hypothalamus, the frontal
lobe, anterior cingulate cortex, insula, amygdala, PAG,
nucleus cuneiformis and the rostral ventromedial medulla.72
In light of the similarities between dyspnoea and pain, it is
not surprising that the brain regions that so far have been
associated with dyspnoea (the insular cortex, anterior
cingulate cortex and the amygdala) have also been impli-
cated in pain perception.73,74 The insula plays a central role
in the conscious awareness of body state75 and is important in
pain perception76. The anterior cingulate cortex, which is
involved in emotional processing,77 has been widely impli-
cated in cognitive and affective pain processing.37,78 The
amygdala, which has a well-established involvement in
emotion processing79 and conditioning,80 is thought to be
central to the modulation of pain,81 possibly throughattention.82 Interactions between brain regions are central
to most sensory perception, and identifying networks that
govern higher-order functions is therefore crucial to further
our understanding of dyspnoea. One could reasonably spec-
ulate that the brain regions associated with dyspnoea are
part of a complex network that is shared in part with other
types of sensations, including pain. Indeed, early observa-
tional studies have shown some commonalities in brain
activation between pain and dyspnoea,83e85 highlighting the
insular cortex, anterior cingulate cortex, amygdala, PAG and
thalamus. To better address the clinical aspects of dyspnoea,
this line of investigationmay be continued using longer,more
realistic, dyspnoea stimuli as well as sophisticated methods
for physiological noise correction. Intervention studies that
carefully link brain imaging results to reliable behavioural
measures may also improve our current understanding of
dyspnoea. This would generate a well-controlled, more
detailed picture of the brain mechanisms involved in dysp-
noea specifically, and assist in disentangling these frombrain
areas that are merely generally associated with unpleasant
sensations.
It is our opinion, however, that dyspnoea is not merely
a carbon copy of pain. Patients suffering fromdyspnoea often
have very different pathologies, and it is likely that the
psychological components of these conditions are also not
identical. As such, blindly copying pain research will most
likely not be fruitful in dyspnoea research. Nevertheless,
considering the commonalities between dyspnoea and pain,
using themore advancedpain field as a roadmap for dyspnoea
research might be a reasonable strategy,33,35 a point which
was raised as early as 1956.86 For example, the insula may
play a part in mediating the influence of expectations
(including anxiety) on the experience of dyspnoea, as has
been suggested for pain.37 A study on relief from dyspnoea59
has suggested the presence of a dyspnoea modulatory
network, similar to what has been observed in pain. Investi-
gating relief and reward processingmay aid the development
of new therapeutic targets and would mirror research previ-
ously done in pain.87 Furthermore, results from pain research
have highlighted brain regions that may be prospective
targets in future dyspnoea research. For example, one might
also expect the prefrontal cortex to be important for dysp-
noea (as in pain88,89). Indeed, Evans et al.58 did report acti-
vation in the prefrontal cortex, however, other studies have
failed to repeat this observation.
The challenges and potential of imaging
Magnetic resonance imaging (MRI) may be crucial to the
further identification of brain mechanisms in dyspnoea.
Two techniques in particular are considered to hold a lot of
potential; blood oxygen level dependant (BOLD) functional
MRI (FMRI)90 and arterial spin labelling (ASL).91
BOLD FMRI is an indirect measure of changes in cerebral
blood flow, while ASL is a measure of cerebral blood flow in
absolute units using an endogenous tracer (magnetically
labelled water protons). BOLD FMRI offers high spatial
resolution, but has limited sensitivity for low-frequency
tasks and cannot be used to measure a tonic state, such as
chronic dyspnoea. ASL does not share this limitation, and
may therefore be important to further investigations of
chronic conditions. Compared with BOLD FMRI, ASL has
814 M. Herigstad et al.certain drawbacks such as smaller spatial coverage, rela-
tively low signal-to-noise ratio (which in turn introduces
a need for more subjects and/or longer imaging time),
however, novel acquisition schemes are addressing these
limitations,92 making ASL a much more attractive imaging
technique.
The successful further investigation of brain mechanisms
underlying dyspnoea depends on several factors. Firstly, it is
important to use a realistic dyspnoea stimulus that is
compatible with FMRI. Physiological noise relating to respi-
ration degrades MR image quality61 and minor alterations in
blood gases may affect the interpretation of the FMRI
signal.65,93,94 Satisfactorily addressing these challenges is
crucial to future dyspnoea research. Secondly, it is important
to look beyond experimentally induced dyspnoea. This,
however, introduces practical concerns such as the reduced
ability of some patients to be supine for an extended period
of time. Furthermore, some patients suffer primarily from
exertion-related dyspnoea, which may be difficult to induce
in a manner that is compatible with FMRI. Finally, it is highly
important that future research uses appropriate experi-
mental paradigms in order to accurately correlate neuronal
activation with reliable behavioural measures. Future
research should therefore employ predictive, and thus
testable, models of brain function (e.g.95), rather than
aimlessly search for static “blobs” of activation.
Measuring electrical activity in the brain with magneto-
encephalography (MEG) and EEG also holds great potential
for investigating dyspnoea mechanisms. Synaptic trans-
mission creates an electrical current in the brain (measured
by EEG), which in turn generates magnetic field variations
(measured by MEG). As such, MEG and EEG are direct
measures of synaptic transmission in the brain, unlike FMRI,
which is indirect due to its haemodynamic nature. MEG and
EEG have very high temporal resolution (i.e. milliseconds),
are non-invasive and can be conducted in an upright position,
which may be of benefit when studying patients suffering
from severe orthopnoea.96 MEG is less susceptible to signal
loss across the skull than EEG and displays better spatial
resolution, but is more expensive than EEG by far. However,
both MEG and EEG are ill equipped to measure subcortical
activation and cannot provide structural information.
With the advent of even more sophisticated acquisition
schemes, such as more powerful MRI scanners (3T and
above), neuroimaging will become even more central to
dyspnoea research.
Conclusions
Dyspnoea research lags years behind pain research. In light
of the similarities between chronic dyspnoea and chronic
pain, a number of concepts successfully used in the study of
pain might reasonably be applied to guide the future
approaches to dyspnoea research. However, one should be
careful not to automatically assume similarities between
the two conditions. It is highly important for the future of
dyspnoea research and, ultimately, dyspnoea treatment, to
invest time and effort into identifying and addressing
factors that are unique to dyspnoea. These factors must be
seen in the context of dyspnoea as a multidimensional
disease, in which there may often be a mismatch between
disease severity and symptom perception. Cognitive andaffective factors, including how threat and disease-related
anxiety affect symptom perception, are thus crucial to our
understanding of dyspnoea and should be incorporated in
future research. Investigating brain mechanisms underlying
dyspnoea perception is likely to aid the development of
novel therapies. This includes identifying new drug targets,
building the capacity to non-invasively measure responses
to novel treatments, i.e. making quantitative measures of
hitherto subjective sensations, and also paving the way for
individualised treatments. In order to identify novel treat-
ments, the cognitive and affective dimension of dyspnoea
must be better understood, building both on clinical
observations and on new neuroimaging techniques.
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